SRZN 8-K 2026-11-09

Surrozen, Inc./DE (SRZN) 8-K dated 2026-11-09 — accession 0001193125-26-453641.

Surrozen, Inc./DE (SRZN) is a biotechnology company listed on US.

Surrozen, Inc./DE filed a 8-K on 2026-11-09. Accession 0001193125-26-453641.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SRZN revenue for 2025-12-31 was $3.5M. Net income was -$242.0M. Revenue was down 67.4% from 2024-12-31 to 2025-12-31. SRZN currently screens at market cap $71.6M.

Not investment advice. The SRZN SEC hub lists recent forms. The stock page is the research view.